About Tivity Health (NASDAQ:TVTY)
Tivity Health, Inc. provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers. It also provides health plans through WholeHealth Living program; and health services, such as chiropractic care, acupuncture, physical therapy, occupational therapy, speech therapy, and others. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was founded in 1981 and is headquartered in Franklin, Tennessee.
Industry, Sector and Symbol
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
SectorMedical
SymbolNASDAQ:TVTY
CUSIP42224510
Phone615-614-4929
Debt
Debt-to-Equity RatioN/A
Current Ratio0.62%
Quick Ratio0.62%
Price-To-Earnings
Trailing P/E Ratio23.56
Forward P/E Ratio18.26
P/E Growth1.69
Sales & Book Value
Annual Sales$556.94 million
Price / Sales2.82
Cash Flow$2.1301 per share
Price / Cash18.52
Book Value$6.86 per share
Price / Book5.75
Profitability
EPS (Most Recent Fiscal Year)$1.68
Net Income$63.71 million
Net Margins11.44%
Return on Equity29.17%
Return on Assets11.27%
Miscellaneous
Employees475
Outstanding Shares39,850,000
Tivity Health (NASDAQ:TVTY) Frequently Asked Questions
What is Tivity Health's stock symbol?
Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."
How were Tivity Health's earnings last quarter?
Tivity Health (NASDAQ:TVTY) issued its earnings results on Monday, April, 23rd. The company reported $0.49 EPS for the quarter, meeting the Zacks' consensus estimate of $0.49. The firm had revenue of $149.90 million for the quarter, compared to analyst estimates of $154.32 million. Tivity Health had a return on equity of 29.17% and a net margin of 11.44%. Tivity Health's revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.42 earnings per share. View Tivity Health's Earnings History.
What guidance has Tivity Health issued on next quarter's earnings?
Tivity Health issued an update on its FY18 earnings guidance on Monday, April, 23rd. The company provided EPS guidance of $2.12-2.20 for the period, compared to the Thomson Reuters consensus estimate of $2.16. The company issued revenue guidance of $607-625 million, compared to the consensus revenue estimate of $617.52 million.
What price target have analysts set for TVTY?
8 Wall Street analysts have issued 12-month price objectives for Tivity Health's shares. Their predictions range from $41.00 to $53.00. On average, they anticipate Tivity Health's stock price to reach $47.3750 in the next twelve months. View Analyst Ratings for Tivity Health.
What are Wall Street analysts saying about Tivity Health stock?
Here are some recent quotes from research analysts about Tivity Health stock:
- 1. Cantor Fitzgerald analysts commented, "Mixed 1Q18 results. Revenue of $150 million (+6.4% y/y) was below our estimate of $156 million and consensus of $154 million. Adjusted EBITDA margins remained healthy at 22.1%. Adjusted EPS of $0.49 were in line with consensus but below our estimate of $0.52." (4/23/2018)
- 2. According to Zacks Investment Research, "Tivity Health, Inc. provides health management services. The company offers services which include chiropractic services, physical therapy, occupational therapy, speech therapy, acupuncture, massage and complementary and alternative medicine services. Its network comprises SilverSneakers(R), Prime(R) Fitness and WholeHealth Living (TM). Tivity Health, Inc., formerly known as Healthways, Inc., is based in Franklin, Tennessee. " (2/28/2018)
Who are some of Tivity Health's key competitors?
Who are Tivity Health's key executives?
Tivity Health's management team includes the folowing people:
- Mr. Donato J. Tramuto, CEO & Director (Age 61)
- Mr. Glenn Hargreaves, Chief Accounting Officer & Controller (Age 51)
- Ms. Mary S. Flipse, Chief Legal Officer (Age 51)
- Mr. Adam C. Holland, Chief Financial Officer (Age 39)
- Mr. Paul Edmisten, Chief Information Officer
Has Tivity Health been receiving favorable news coverage?
Media stories about TVTY stock have been trending somewhat positive this week, according to Accern Sentiment. The research firm rates the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Tivity Health earned a media sentiment score of 0.24 on Accern's scale. They also assigned media headlines about the company an impact score of 45.70 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.
How do I buy shares of Tivity Health?
Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tivity Health's stock price today?
One share of TVTY stock can currently be purchased for approximately $39.45.
How big of a company is Tivity Health?
Tivity Health has a market capitalization of $1.60 billion and generates $556.94 million in revenue each year. The company earns $63.71 million in net income (profit) each year or $1.68 on an earnings per share basis. Tivity Health employs 475 workers across the globe.
How can I contact Tivity Health?
Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at 615-614-4929 or via email at [email protected]
MarketBeat Community Rating for Tivity Health (TVTY)
MarketBeat's community ratings are surveys of what our community members think about Tivity Health and other stocks. Vote "Outperform" if you believe TVTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TVTY will underperform the S&P 500 over the long term. You may vote once every thirty days.
Tivity Health (NASDAQ:TVTY) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for Tivity Health in the last 12 months. Their average twelve-month price target is $47.3750, suggesting that the stock has a possible upside of 20.09%. The high price target for TVTY is $53.00 and the low price target for TVTY is $41.00. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.88 | 2.86 | 2.86 | 2.86 |
| Ratings Breakdown: | 0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $47.3750 | $47.1429 | $45.4286 | $43.1429 |
| Price Target Upside: | 20.09% upside | 23.90% upside | 43.76% upside | 6.00% upside |
Tivity Health (NASDAQ:TVTY) Consensus Price Target History
Tivity Health (NASDAQ:TVTY) Analyst Ratings History
Show:
(Data available from 4/24/2016 forward)
Tivity Health (NASDAQ:TVTY) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Tivity Health (NASDAQ TVTY) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.73%
Tivity Health (NASDAQ TVTY) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/2/2018 | Donato Tramuto | CEO | Sell | 20,000 | $39.30 | $786,000.00 | |  |
| 3/1/2018 | Donato Tramuto | CEO | Sell | 20,000 | $38.53 | $770,600.00 | 189,596 | |
| 11/21/2017 | Conan Laughlin | Director | Sell | 140,000 | $34.90 | $4,886,000.00 | | |
| 11/17/2017 | Conan Laughlin | Director | Sell | 490,000 | $34.34 | $16,826,600.00 | | |
| 11/15/2017 | Conan Laughlin | Director | Sell | 115,087 | $33.87 | $3,897,996.69 | | |
| 11/6/2017 | Conan Laughlin | Director | Sell | 120,000 | $47.52 | $5,702,400.00 | | |
| 11/3/2017 | Mary Flipse | Insider | Sell | 5,000 | $48.11 | $240,550.00 | 45,167 | |
| 11/2/2017 | Glenn Hargreaves | CAO | Sell | 5,805 | $45.15 | $262,095.75 | 44,448 | |
| 9/26/2017 | Glenn Hargreaves | Insider | Sell | 7,137 | $40.00 | $285,480.00 | 52,180 | |
| 9/25/2017 | Mary Flipse | Insider | Sell | 7,808 | $39.00 | $304,512.00 | 57,975 | |
| 8/21/2017 | Glenn Hargreaves | Insider | Sell | 23,448 | $37.78 | $885,865.44 | 62,211 | |
| 8/18/2017 | Mary Flipse | Insider | Sell | 14,020 | $37.03 | $519,160.60 | 61,167 | |
| 8/11/2017 | Mary Flipse | Insider | Sell | 1,340 | $37.32 | $50,008.80 | 75,187 | |
| 8/4/2017 | Glenn Hargreaves | Insider | Sell | 21,105 | $38.00 | $801,990.00 | 59,077 | |
| 8/1/2017 | Conan Laughlin | Director | Sell | 1,750,000 | $37.90 | $66,325,000.00 | | |
| 5/3/2017 | Mary Jane England | Director | Sell | 1,763 | $31.95 | $56,327.85 | 19,453 | |
| 4/3/2017 | Mary Jane England | Director | Sell | 2,674 | $29.05 | $77,679.70 | 21,216 | |
| 3/3/2017 | Mary Jane England | Director | Sell | 2,340 | $28.60 | $66,924.00 | 23,890 | |
| 3/1/2017 | Conan Laughlin | Insider | Sell | 2,000,000 | $28.30 | $56,600,000.00 | | |
| 2/3/2017 | Mary Jane England | Director | Sell | 2,343 | $25.55 | $59,863.65 | 26,230 | |
| 1/3/2017 | Mary Jane England | Director | Sell | 2,298 | $22.40 | $51,475.20 | 28,573 | |
| 11/18/2016 | Mary Jane England | Director | Sell | 3,600 | $22.26 | $80,136.00 | 30,871 | |
| 11/4/2016 | Donato Tramuto | CEO | Buy | 5,060 | $19.95 | $100,947.00 | 275,442 | |
| 11/4/2016 | Robert J Greczyn Jr | Director | Buy | 5,000 | $19.55 | $97,750.00 | 30,578 | |
| 8/26/2016 | Mary Jane England | Director | Sell | 3,816 | $24.78 | $94,560.48 | 39,068 | |
| 11/13/2015 | Conan Laughlin | Director | Buy | 47,600 | $12.65 | $602,140.00 | 6,203 | |
| 11/12/2015 | Conan Laughlin | Director | Buy | 252,400 | $12.49 | $3,152,476.00 | 6,203 | |
| 11/5/2015 | Conan Laughlin | Director | Buy | 350,000 | $11.51 | $4,028,500.00 | 6,203 | |
| 11/3/2015 | Donato Tramuto | CEO | Buy | 8,740 | $11.47 | $100,247.80 | 304,186 | |
| 11/3/2015 | Lee Shapiro | Director | Buy | 4,359 | $11.42 | $49,779.78 | 10,562 | |
| 7/31/2014 | North Tide Capital, Llc | Major Shareholder | Sell | 100,000 | $17.29 | $1,729,000.00 | | |
| 12/18/2013 | North Tide Capital, Llc | major shareholder | Buy | 140,000 | $14.11 | $1,975,400.00 | | |
| 11/7/2013 | Donato Tramuto | Director | Buy | 4,200 | $11.77 | $49,434.00 | 4,200 | |
| 10/29/2013 | Alfred Lumsdaine | CFO | Buy | 5,000 | $10.80 | $54,000.00 | | |
| 8/14/2013 | Alfred Lumsdaine | CFO | Sell | 9,425 | $18.64 | $175,682.00 | 17,821 | |
| 8/14/2013 | Ben Leedle, Jr. | CEO | Sell | 293,984 | $18.68 | $5,491,621.12 | 201,814 | |
| 6/3/2013 | Jay C Bisgard | Director | Sell | 4,869 | $14.58 | $70,990.02 | | |
| 5/17/2013 | Jay C Bisgard | Director | Sell | 2,039 | $14.50 | $29,565.50 | | |
| 5/14/2013 | Jay C Bisgard | Director | Sell | 18,343 | $14.51 | $266,156.93 | | |
| 5/9/2013 | John W Ballantine | Director | Sell | 27,400 | $14.02 | $384,148.00 | | |
(Data available from 1/1/2013 forward)
Tivity Health (NASDAQ TVTY) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Tivity Health (TVTY) Issues Earnings Results, Meets Estimates
www.americanbankingnews.com - April 24 at 7:52 AM |
| Tivity Health (TVTY) Rating Reiterated by Cantor Fitzgerald
www.americanbankingnews.com - April 23 at 9:40 PM |
| Tivity Health (TVTY) Releases FY18 Earnings Guidance
www.americanbankingnews.com - April 23 at 5:32 PM |
 | Tivity Health EPS in-line, misses on revenue
seekingalpha.com - April 23 at 4:41 PM |
 | Tivity Health: 1Q Earnings Snapshot
finance.yahoo.com - April 23 at 4:41 PM |
| Tivity Health Reports First-Quarter 2018 Results and Affirms Financial Guidance
finance.yahoo.com - April 23 at 4:41 PM |
| Analyzing Caladrius Biosciences (CLBS) & Tivity Health (TVTY)
www.americanbankingnews.com - April 22 at 9:14 AM |
| $153.72 Million in Sales Expected for Tivity Health (TVTY) This Quarter
www.americanbankingnews.com - April 19 at 1:52 AM |
| Financial Comparison: Caladrius Biosciences (CLBS) vs. Tivity Health (TVTY)
www.americanbankingnews.com - April 18 at 3:20 AM |
| Zacks: Analysts Expect Tivity Health (TVTY) to Post $0.49 EPS
www.americanbankingnews.com - April 17 at 11:08 PM |
| Tivity Health (TVTY) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - April 17 at 4:13 AM |
| Tivity Health (TVTY) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 13 at 9:39 AM |
| Comparing Fresenius Medical Care (FMS) and Tivity Health (TVTY)
www.americanbankingnews.com - April 12 at 11:27 AM |
| Tivity Health (TVTY) Downgraded by Zacks Investment Research to "Sell"
www.americanbankingnews.com - April 11 at 1:25 PM |
| Tivity Health (TVTY) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 11 at 11:37 AM |
| Tivity Health CEO Donato Tramuto Named Chairman of Robert F. Kennedy Human Rights Leadership Council
finance.yahoo.com - April 9 at 4:42 PM |
| Tivity Health (TVTY) CEO Sells $786,000.00 in Stock
www.americanbankingnews.com - April 4 at 10:39 PM |
| Catasys (CATS) versus Tivity Health (TVTY) Critical Analysis
www.americanbankingnews.com - April 3 at 5:06 PM |
| Tivity Health (TVTY) Expected to Announce Quarterly Sales of $153.72 Million
www.americanbankingnews.com - April 3 at 4:51 AM |
| Tivity Health (TVTY) Upgraded to Buy by Zacks Investment Research
www.americanbankingnews.com - April 2 at 8:04 PM |
| Tivity Health (TVTY) Given New $50.00 Price Target at Oppenheimer
www.americanbankingnews.com - April 2 at 10:44 AM |
| Tivity Health (TVTY) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - April 1 at 7:00 PM |
| Zacks: Brokerages Anticipate Tivity Health Inc (TVTY) Will Post Earnings of $0.49 Per Share
www.americanbankingnews.com - April 1 at 1:22 AM |
| Tivity Health (TVTY) Downgraded by BidaskClub
www.americanbankingnews.com - March 30 at 5:40 PM |
| Tivity Health (TVTY) Lifted to Buy at BidaskClub
www.americanbankingnews.com - March 24 at 12:29 PM |
| Tivity Health to Issue First Quarter 2018 Financial Results After Market Close on April 23
finance.yahoo.com - March 19 at 4:39 PM |
| Tivity Health Inc (TVTY) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - March 17 at 11:50 AM |
| Tivity Health Inc (TVTY) Expected to Post Quarterly Sales of $153.72 Million
www.americanbankingnews.com - March 16 at 1:54 AM |
| Tivity Health Inc (TVTY) Expected to Post Earnings of $0.49 Per Share
www.americanbankingnews.com - March 14 at 11:16 PM |
| Zacks.com featured highlights include: Caterpillar, Cinemark, Healthways, Boeing and Concho
finance.yahoo.com - March 8 at 9:22 AM |
| Tivity Health Inc (TVTY) CEO Sells $770,600.00 in Stock
www.americanbankingnews.com - March 5 at 6:40 PM |
| Royce & Associates LP Sells 9,112 Shares of Tivity Health Inc (TVTY)
www.americanbankingnews.com - March 5 at 11:08 AM |
| Kennedy Capital Management Inc. Has $17.98 Million Position in Tivity Health Inc (TVTY)
www.americanbankingnews.com - March 3 at 3:30 PM |
| Tivity Health Inc (TVTY) Holdings Decreased by Wells Fargo & Company MN
www.americanbankingnews.com - March 3 at 8:34 AM |
| Tivity Health (TVTY) Upgraded by Zacks Investment Research to Strong-Buy
www.americanbankingnews.com - February 28 at 1:06 PM |
| Tivity Health Inc Expected to Post FY2018 Earnings of $2.17 Per Share (TVTY)
www.americanbankingnews.com - February 28 at 11:26 AM |
| Carillon Tower Advisers Inc. Purchases New Stake in Tivity Health Inc (TVTY)
www.americanbankingnews.com - February 28 at 5:26 AM |
| Research Analysts Offer Predictions for Tivity Health Inc's FY2019 Earnings (TVTY)
www.americanbankingnews.com - February 27 at 2:42 PM |
| Tivity Health (TVTY) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - February 27 at 2:14 PM |
| Tivity Health Inc (TVTY) Expected to Post Quarterly Sales of $156.67 Million
www.americanbankingnews.com - February 27 at 2:28 AM |
| Tivity Health Inc (TVTY) Expected to Post FY2018 Earnings of $2.17 Per Share
www.americanbankingnews.com - February 26 at 5:28 AM |
| Tivity Health Inc (TVTY) to Post Q1 2018 Earnings of $0.52 Per Share, SunTrust Banks Forecasts
www.americanbankingnews.com - February 26 at 1:28 AM |
| Oppenheimer Research Analysts Raise Earnings Estimates for Tivity Health Inc (TVTY)
www.americanbankingnews.com - February 26 at 1:28 AM |
| Tivity Health Inc (TVTY) Forecasted to Post Q1 2018 Earnings of $0.48 Per Share
www.americanbankingnews.com - February 26 at 1:28 AM |
| Barrington Research Weighs in on Tivity Health Inc's Q1 2018 Earnings (TVTY)
www.americanbankingnews.com - February 26 at 1:28 AM |
| Zacks: Brokerages Expect Tivity Health Inc (TVTY) to Announce $0.47 Earnings Per Share
www.americanbankingnews.com - February 25 at 11:08 PM |
| Pinebridge Investments L.P. Acquires 2,849 Shares of Tivity Health Inc (TVTY)
www.americanbankingnews.com - February 25 at 9:30 AM |
| Tivity Health Inc (TVTY) Shares Bought by Citadel Advisors LLC
www.americanbankingnews.com - February 25 at 4:52 AM |
| Tivity Health (TVTY) Stock Rating Reaffirmed by Chardan Capital
www.americanbankingnews.com - February 24 at 6:28 PM |
| Systematic Financial Management LP Increases Stake in Tivity Health Inc (TVTY)
www.americanbankingnews.com - February 24 at 12:02 PM |
Tivity Health (NASDAQ:TVTY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Tivity Health (NASDAQ:TVTY) Income Statement, Balance Sheet and Cash Flow Statement
Tivity Health (NASDAQ TVTY) Stock Chart for Tuesday, April, 24, 2018
Loading chart…
